Drug intelligence / Profile preview

aripiprazole + methylprednisolone + prednisolone

Development stage
Unknown
Lead developer
Otsuka Holdings
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous, Intraarticular, Intralesional, Rectal, Ophthalmic
01

Overview

This is a combination of the atypical antipsychotic aripiprazole with two corticosteroids (methylprednisolone and prednisolone). Aripiprazole works by balancing dopamine and serotonin levels in the brain to help treat schizophrenia, bipolar disorder, and as an adjunctive treatment for depression. Methylprednisolone and prednisolone are corticosteroids used to treat inflammation and immune reactions across various organ systems. When used together, careful monitoring is required as corticosteroids can potentially cause psychiatric symptoms including psychosis, and antipsychotics may be used to manage these steroid-induced psychiatric effects.

02

Targets

HTR2A (Serotonin receptor 5-HT2A)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))DRD2 (Dopamine D2 Receptor)GR (Glucocorticoid receptor)DRD3 (Dopamine receptor D3)

Beyond the preview

Go deeper on aripiprazole + methylprednisolone + prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aripiprazole + methylprednisolone + prednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call